Surveys on the use of cardiac markers in the UK

Annals of Clinical Biochemistry

Volumn 40, Issue 2, 2003, Pages 138-142

  Tsang, Wing Man ^a,e   Owen, Avril M ^b   Collinson, Paul O ^c   Barth, Julian H ^d  

^a ROYAL HOSPITAL HASLAR   (United Kingdom)

^b YSBYTY GWYNEDD   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d LEEDS GENERAL INFIRMARY   (United Kingdom)

^e Merthyr Tydfil   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; BIOCHEMICAL MARKER; CREATINE KINASE MB; HYDROXYBUTYRATE DEHYDROGENASE; LACTATE DEHYDROGENASE; TROPONIN;

ARTICLE; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; COST BENEFIT ANALYSIS; DIAGNOSTIC TEST; DISEASE SEVERITY; HEALTH SURVEY; HEART INFARCTION; HUMAN; LABORATORY TEST; PRIORITY JOURNAL; PROGNOSIS; UNITED KINGDOM;

CHEMISTRY, CLINICAL; GREAT BRITAIN; HUMANS; MYOCARDIAL INFARCTION; QUESTIONNAIRES; TIME FACTORS; TROPONIN;

EID: 0037352412     PISSN: 00045632     EISSN: None     Source Type: Journal    
DOI: 10.1258/000456303763046058     Document Type: Article

References (19)

1. Brikhead J, Goldacre M, Mason A, Wilkinson E, Amess M, Cleary R, eds. Heath Outcome Indicators: Myocardial Infarction. Report of a Working Group to the Department of Health. Oxford: National Centre for Health Outcomes Development, 1999
2. Nomenclature and criteria for diagnosis of ischemic heart disease. Report of the Joint International Society and Federation of Cardiology/World Health Organization task force on standardization of clinical nomenclature. Circulation 1979; 59: 607-9
3. Collinson PO, Boa FG, Gaze DC. Measurement of cardiac troponins. Ann Clin Biochem 2001; 38: 423-49
4. IFCC Scientific Division, Committee on Standardization of Markers of Cardiac Damage. Use of biochemical markers in acute coronary syndromes. Clin Chem Lab Med 1999; 37: 687-93
5. Wu AHB, Apple FS, Gibler WB, Jesse RL, Warshaw MH, Waldes R. National Academy of Clinical Biochemistry Standards of Laboratory Practice. Recommendations for the use of cardiac markers in coronary artery disease. Clin Chem 1999; 45: 1104-21
6. Myocardial infarction redefined: a consensus document of the Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. Eur Heart J 2000; 21: 1502-13
7. Myocardial infarction redefined: a consensus document of the joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36: 959-69
8. ACC/AMA guidelines for the management of patients with unstable angina and non-ST segment elevation myocardial infarction. J Am Coll Cardiol 2000; 36: 970-1062
9. National Institute of Clinical Excellence. The use of glycoprotein llb/ llla inhibitors in the treatment of acute coronary syndromes. NICE Technology Appraisal Guidance No. 12. London: National Institute of Clinical Excellence, 2000
10. Apple FS, Murakami M, Panteghini M, Christensen RH, Dati F, Johannes M, et al. International survey on the use of cardiac markers. Clin Chem 2001; 47: 587-8
11. Tormey WP. The diagnosis and management of acute myocardial infarction: a role for biochemical markers? Ann Clin Biochem 1996; 33: 477-81
12. Wu AHB. Risk stratification of cardiac troponin in ischaemic and non-ischaemic cardiac diseases and procedures. Clin Biochem Rev 2000; 21: 79-86
13. Frey N, Dietz A, Kurowski V, Giannitisis E, Tolg R, Wiegand U, et al. Angiographic correlates of a positive troponin T test in patients with unstable angina. Crit Care Med 2001; 29: 1130-6
14. Balk EM, Ioannidis JP, Salem D, Chew PW, Lau J. Accuracy of biochemical markers to diagnose acute cardiac ischaemia in the emergency department: a meta-analysis. Ann Emerg Med 2001; 37: 478-94
15. Braunwald E, Califf RM, Cannon CP, Fox KA, Fuster VA, Gibler WB, et al. Redefining medical treatment in the management of unstable angina. Am J Med 2000; 108: 41-53
16. Kanna M, Nogogi H, Miyazaki S, Morii I, Yasuda S, Sutanni Y, et al. Usefulness of serum troponin T levels on day three or four in predicting survival after acute myocardial infarction. Am J Cardiol 2001; 87: 294-7
17. Ottani F, Galvani M, Nicolini FA, Ferrini D, Pozzati A, Di Pasquale G, et al. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 2000; 140: 917-27
18. Jurlander B, Clemmensen P, Wagner GS, Grande P. Very early diagnosis and risk stratification of patients admitted with suspected acute myocardial infarction by the combined evaluation of a single serum value of cardiac troponin-T, myoglobin, and creatine kinase MB (mass). Eur Heart J 2000; 21: 382-9
19. Business case for troponin.http://www.acb.org.uk/docex/Business.Docs.htm